Dr. Angela Chen, MD

NPI: 1710914262
Total Payments
$203,858
2022 Payments
$144.34
Companies
4
Transactions
10
Medicare Patients
112
Medicare Billing
$10,323

Payment Breakdown by Category

Research$202,911 (99.5%)
Travel$547.30 (0.3%)
Food & Beverage$399.42 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $202,911 4 99.5%
Travel and Lodging $547.30 1 0.3%
Food and Beverage $399.42 5 0.2%

Payments by Type

Research
$202,911
4 transactions
General
$946.72
6 transactions

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $203,166 7 $0 (2019)
Dentsply Sirona Inc $547.30 1 $0 (2019)
Organon LLC $125.00 1 $0 (2022)
Boston Scientific Corporation $19.34 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $144.34 2 Organon LLC ($125.00)
2019 $606.05 2 Dentsply Sirona Inc ($547.30)
2018 $203,003 5 Merck Sharp & Dohme Corporation ($203,003)
2017 $104.49 1 Merck Sharp & Dohme Corporation ($104.49)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/03/2022 Organon LLC IMPLANON (Drug) Food and Beverage In-kind items and services $125.00 General
Category: ETONOGESTREL
10/05/2022 Boston Scientific Corporation EMBLEM MRI S-ICD (Device) Food and Beverage In-kind items and services $19.34 General
Category: EMBLEM_CRM
10/19/2019 Merck Sharp & Dohme Corporation NEXPLANON (Drug) Food and Beverage In-kind items and services $58.75 General
Category: WOMENS HEALTH
07/10/2019 Dentsply Sirona Inc TENEO (Device) Travel and Lodging In-kind items and services $547.30 General
Category: Dental Equipment
10/19/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $91.84 General
06/15/2018 Merck Sharp & Dohme Corporation IMPLANON (Drug) Cash or cash equivalent $82,645.69 Research
Study: Identification and removal of the non palpable etonorgestrel contraceptive implant. • Category: WOMENS HEALTH
02/22/2018 Merck Sharp & Dohme Corporation NEXPLANON (Drug) In-kind items and services $9,326.90 Research
Study: Identification and removal of the non palpable etonorgestrel contraceptive implant. • Category: WOMENS HEALTH
02/22/2018 Merck Sharp & Dohme Corporation NEXPLANON (Drug) In-kind items and services $7,631.10 Research
Study: Identification and removal of the non palpable etonorgestrel contraceptive implant. • Category: WOMENS HEALTH
02/16/2018 Merck Sharp & Dohme Corporation IMPLANON (Drug) Cash or cash equivalent $103,307.11 Research
Study: Identification and removal of the non palpable etonorgestrel contraceptive implant. • Category: WOMENS HEALTH
05/05/2017 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $104.49 General

Research Studies & Clinical Trials

Study Name Company Amount Records
Identification and removal of the non palpable etonorgestrel contraceptive implant. Merck Sharp & Dohme Corporation $202,911 4

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 36 36 $26,688 $3,144
2022 1 25 26 $22,308 $2,420
2021 2 40 41 $30,278 $4,021
2020 1 11 12 $4,872 $738.11
Total Patients
112
Total Services
115
Medicare Billing
$10,323
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 24 24 $20,592 $2,331 11.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 12 $6,096 $813.27 13.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 26 $22,308 $2,420 10.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 26 27 $23,166 $3,029 13.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 14 14 $7,112 $992.29 14.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 11 12 $4,872 $738.11 15.2%

About Dr. Angela Chen, MD

Dr. Angela Chen, MD is a Obstetrics healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710914262.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Chen, MD has received a total of $203,858 in payments from pharmaceutical and medical device companies, with $144.34 received in 2022. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "" ($202,911).

As a Medicare-enrolled provider, Chen has provided services to 112 Medicare beneficiaries, totaling 115 services with total Medicare billing of $10,323. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics
  • Location Los Angeles, CA
  • Active Since 06/27/2006
  • Last Updated 02/12/2015
  • Taxonomy Code 207VX0000X
  • Entity Type Individual
  • NPI Number 1710914262

Products in Payments

  • IMPLANON (Drug) $186,078
  • NEXPLANON (Drug) $17,017
  • TENEO (Device) $547.30
  • EMBLEM MRI S-ICD (Device) $19.34

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics Doctors in Los Angeles